Skip Navigation

Cardiovascular Research 2000 47(4):813-818; doi:10.1016/S0008-6363(00)00130-9
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kosch, M.
Right arrow Articles by Barenbrock, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kosch, M.
Right arrow Articles by Barenbrock, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy

Markus Kosch*, Martin Hausberg, Klaus Vormbrock, Klaus Kisters, Gert Gabriels, Karl Heinz Rahn and Michael Barenbrock

Department of Internal Medicine D, University of Münster, Albert-Schweitzer-Strasse 33, D-48129, Münster, Germany

* Corresponding author. Tel.: +49-251-834-7523; fax: +49-251-834-7545 koschm{at}uni-muenster.de

Objective: The endothelium is a newly recognised target tissue of parathyroid hormone (PTH). It is not clear whether hyperparathyroidism affects endothelial function and whether parathyroidectomy (Ptx) has an influence on arterial vessel wall properties. We studied brachial flow-mediated vasodilation (FMD) and brachial and carotid intima-media thickness (IMT) in patients with primary hyperparathyroidism (pHPT) before and after Ptx and in healthy controls. Methods: 19 patients with pHPT (mean+SEM, age 45±4.7 years, PTH 238±52 ng/l) were studied. Diabetes, hypertension and vascular disease were excluded. Twenty healthy volunteers matched for age, sex and blood pressure served as controls. Enddiastolic diameter, FMD and nitroglycerine-induced (NMD) dilation of the brachial artery were measured by a multigate pulsed doppler system (echo-tracking), IMT was determined using automatic analysis of the M-line signal. Healthy volunteers where studied on one occasion, patients were studied at baseline and 6 months after Ptx. Results: Six months after Ptx PTH had decreased to normal, blood pressure levels remained unchanged. Endothelium dependent FMD at baseline was impaired in patients compared to controls (4.7±1.2 vs. 18.2±3.7%, P<0.01), however, FMD improved significantly after Ptx (16.7±3.0%, P<0.01). Nitroglycerine-induced dilation, IMT and artery diameter were not different between groups and did not change after Ptx. Conclusions: Impaired endothelium dependent vasodilation in patients with primary hyperparathyroidism improves after successful parathyroidectomy. Endothelial dysfunction associated with primary hyperparathyroidism occurs without detectable structural wall alterations of the brachial artery and appears therefore to be an early and reversible arterial alteration.

KEYWORDS Hormones; Endothelial function; Ultrasound; Blood flow; Vasoconstriction/dilation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. D. Walker, D. J. McMahon, W. B. Inabnet, R. M. Lazar, I. Brown, S. Vardy, F. Cosman, and S. J. Silverberg
Neuropsychological Features in Primary Hyperparathyroidism: A Prospective Study
J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 1951 - 1958.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. Drechsler, V. Krane, D. C Grootendorst, E. Ritz, K. Winkler, W. Marz, F. Dekker, C. Wanner, and for the German Diabetes and Dialysis Study Investi
The association between parathyroid hormone and mortality in dialysis patients is modified by wasting
Nephrol. Dial. Transplant., May 27, 2009; (2009) gfp260v1.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Covic, P. Kothawala, M. Bernal, S. Robbins, A. Chalian, and D. Goldsmith
Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease
Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1506 - 1523.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. J. Silverberg, E. M. Lewiecki, L. Mosekilde, M. Peacock, and M. R. Rubin
Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop
J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 351 - 365.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.